Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Noxopharm Entered into Research Agreement with the University of Hong Kong
Wednesday, February 01, 2017Noxopharm announces that it has entered into a research agreement with the University of Hong Kong to conduct research into the use of the drug idronoxil NOX active ingredient to treat brain cancer In parallel to the NOX clinical program currently b...
Endo Announces U.S. FDA Approval of Ephedrine Sulfate Injection, USP
Tuesday, January 31, 2017Endo International plc announced that one of its operating companies Par Pharmaceutical has received final approval from the US Food and Drug Administration for its New Drug Application for ephedrine sulfate injection a drug administered parenterally...
Ferring Pharmaceuticals and Enteris BioPharma Enter License Agreement
Tuesday, January 31, 2017Ferring Pharmaceuticals and Enteris BioPharma Inc announced that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris proprietary and patented oral peptide and small molecule delivery pl...
Mallinckrodt to Sell Intrathecal Therapy Business to Piramal Enterprises Limited
Tuesday, January 31, 2017Mallinckrodt plc a leading specialty pharmaceutical company announced it has entered into an agreement under which it will sell its Intrathecal Therapy business to Piramal Enterprises Limiteds subsidiary in the UK Piramal Critical Care for approximat...
Mallinckrodt Completes Sale of its Nuclear Imaging Business to IBA Molecular for $690 million
Monday, January 30, 2017Mallinckrodt plc a leading specialty pharmaceutical company announced that it has closed the sale of its global Nuclear Imaging business to IBA Molecular IBAM for approximately million before tax including upfront and contingent considerations and t...
Astellas and Ironwood Report Positive Top-Line Results from Phase III Linaclotide Trial
Monday, January 30, 2017Astellas Pharma Inc and Ironwood Pharmaceuticals Inc announced topline results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation CC met its primary endpoint Linaclotide is approved in...
Vicore Pharma is granted orphan drug designation from FDA for the treatment of IPF
Saturday, January 28, 2017FDA has granted orphan drug designation for Vicore Pharmas drug candidates C for the treatment of IPF C is thereby approved as an orphan drug in the USA The approval brings C exclusivity on the US market from when the drug will be approved and for y...
CrownBio Announces Expansion of Life Science Division
Friday, January 27, 2017Crown Bioscience a whollyowned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research announced its intention to s...
Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon
Friday, January 27, 2017Medtronic plc MDT announced receipt of an investigational device exemption IDE from the US Food and Drug Administration FDA to initiate a study of the INPACT Admiral drugcoated balloon DCB for a potential new indication in patients with endstage rena...
Celgene to Acquire Delinia, Inc.
Friday, January 27, 2017Celgene Corporation and Delinia Inc a privately held biotechnology company developing novel therapeutics for autoimmune diseases today announced that they have entered into an agreement for the acquisition of Delinia by Celgene The transaction expan...
